Myeloperoxidase: Regulation of Neutrophil Function and Target for Therapy
Open Access
- 21 November 2022
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 11 (11) , 2302
Abstract
Neutrophils, the most abundant white blood cells in humans, are critical for host defense against invading pathogens. Equipped with an array of antimicrobial molecules, neutrophils can eradicate bacteria and clear debris. Among the microbicide proteins is the heme protein myeloperoxidase (MPO), stored in the azurophilic granules, and catalyzes the formation of the chlorinating oxidant HOCl and other oxidants (HOSCN and HOBr). MPO is generally associated with killing trapped bacteria and inflicting collateral tissue damage to the host. However, the characterization of non-enzymatic functions of MPO suggests additional roles for this protein. Indeed, evolving evidence indicates that MPO can directly modulate the function and fate of neutrophils, thereby shaping immunity. These actions include MPO orchestration of neutrophil trafficking, activation, phagocytosis, lifespan, formation of extracellular traps, and MPO-triggered autoimmunity. This review scrutinizes the multifaceted roles of MPO in immunity, focusing on neutrophil-mediated host defense, tissue damage, repair, and autoimmunity. We also discuss novel therapeutic approaches to target MPO activity, expression, or MPO signaling for the treatment of inflammatory and autoimmune diseases.Keywords
Funding Information
- Canadian Institutes of Health Research (MOP-97742, MOP-102619)
This publication has 200 references indexed in Scilit:
- Infection regulates pro-resolving mediators that lower antibiotic requirementsNature, 2012
- The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophagesBiochemical Journal, 2010
- Modulation of arachidonic and linoleic acid metabolites in myeloperoxidase-deficient mice during acute inflammationFree Radical Biology and Medicine, 2010
- Impairment of neutrophil extracellular trap degradation is associated with lupus nephritisProceedings of the National Academy of Sciences, 2010
- Nonresolving InflammationCell, 2010
- Netting neutrophils in autoimmune small-vessel vasculitisNature Medicine, 2009
- Myeloperoxidase: a target for new drug development?British Journal of Pharmacology, 2007
- Getting to the site of inflammation: the leukocyte adhesion cascade updatedNature Reviews Immunology, 2007
- Resolvin E1 and protectin D1 activate inflammation-resolution programmesNature, 2007
- IntegrinsCell, 2002